Chemomab completes End-of-Phase 2 Meeting with the FDA for CM-101
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
Healio1d
Oral vancomycin may offer ‘viable option’ for IBD-related primary sclerosing cholangitis
Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...
Common Antibiotic Could Have Another Big Use, Study Says
A common antibiotic prescribed for infective diarrhea may also be effective in treating a specific type of inflammatory bowel ...
WBBJ-TV12d
Former athlete shares her experience with rare liver disease
Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...
Common antibiotic for diarrhoea shows hope for inflammatory bowel disease: Study
The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...
mp.pl13d
Immunoglobulin A antibodies: prognostic tools with unknown mechanism in primary sclerosing cholangitis
We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...
technologynetworks8d
Antibiotic Shows Promise for Treating Inflammatory Bowel Disease
Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective ...